Latest filingSep 04, 2026Most recent Form 4
TRAX
First Tracks Biotherapeutics, Inc.
NasdaqHealthcarePharmaceutical Preparations
Insider activity for last month from 08/05 to 09/05. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$175M1 sells
Net open-market-$175M3 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period6transactions
- M · Option exercise · dominant3 · 50%
- A · Grants / awards2 · 33%
- S · Open-market sells1 · 17%
Activity by reported role
A joint filing can contribute to multiple roles7transactions
- Director · dominant4 · 57%
- Chief executive officer1 · 14%
- CMO1 · 14%
- PRES1 · 14%
Distinct insiders active
Reporting-owner CIKs by month · peak Aug 2026 (2)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeWare J. AnthonyCommon Stock · Direct
15,660Sep 02, 2026
Ware J. AnthonyStock Option (right to buy) · Direct
0Sep 02, 2026
Faga DanielPerformance Stock Units · Direct
440,485Aug 15, 2026
Lizzul Paul F.Performance Stock Units · Direct
137,651Aug 15, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 05 → Sep 05
LessMore
Top insiders
By absolute net value across the selected period- WA-$1.5M
- LF+$0
- FD+$0
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
TRAX transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| TRAX | Ware J. Anthony | DIR | exercise | 10.6k | $0 | M | — | 0.0% | 09/04 | 09/02 |
| TRAX | Ware J. Anthony | DIR | exercise | 28.5k | $0 | M | — | 0.0% | 09/04 | 09/02 |
| TRAX | Ware J. Anthony | DIR | sale | 39.2k | -$175M | S | — | 0.0% | 09/04 | 09/02 |
| TRAX | Ware J. Anthony | DIR | exercise | 39.2k | $22.5M | M | — | 0.0% | 09/04 | 09/02 |
| TRAX | Lizzul Paul F. | CMO | grant | 60.4k | $0 | A | −6.2% | 08/18 | 08/15 | |
| TRAX | Faga Daniel | PRESCEO | grant | 193k | $0 | A | −6.2% | 08/18 | 08/15 |
First Tracks Biotherapeutics, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at First Tracks Biotherapeutics, Inc.?
Ware J. Anthony, Lizzul Paul F., Faga Daniel.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Ware J. Anthony reported a sale on Sep 02, 2026 valued at $175M. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $1,758,145.35. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.